Press coverage about Health Insurance Innovations (NASDAQ:HIIQ) has trended somewhat positive on Thursday, according to Accern. The research group identifies positive and negative news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Health Insurance Innovations earned a media sentiment score of 0.20 on Accern’s scale. Accern also assigned media coverage about the financial services provider an impact score of 46.59557085874 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

These are some of the news headlines that may have effected Accern Sentiment Analysis’s scoring:

Shares of Health Insurance Innovations (NASDAQ:HIIQ) traded down 7.43% during mid-day trading on Thursday, hitting $33.65. 993,678 shares of the company were exchanged. Health Insurance Innovations has a 12-month low of $4.00 and a 12-month high of $36.35. The stock has a market cap of $419.58 million, a PE ratio of 27.22 and a beta of 0.68. The stock’s 50-day moving average price is $29.58 and its 200 day moving average price is $21.73.

Health Insurance Innovations (NASDAQ:HIIQ) last released its earnings results on Wednesday, August 2nd. The financial services provider reported $0.46 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.13. Health Insurance Innovations had a return on equity of 22.89% and a net margin of 5.56%. The firm had revenue of $61.80 million for the quarter, compared to analyst estimates of $53.69 million. The company’s revenue was up 38.9% compared to the same quarter last year. On average, equities analysts anticipate that Health Insurance Innovations will post $1.53 EPS for the current fiscal year.

A number of analysts have recently issued reports on the stock. UBS AG upgraded shares of Health Insurance Innovations to an “outperform” rating in a research note on Thursday, May 4th. Zacks Investment Research lowered shares of Health Insurance Innovations from a “buy” rating to a “hold” rating in a research note on Monday, June 19th. Craig Hallum reiterated a “buy” rating and set a $38.00 price objective (up previously from $28.00) on shares of Health Insurance Innovations in a research note on Thursday, August 3rd. Raymond James Financial, Inc. upgraded shares of Health Insurance Innovations from a “market perform” rating to an “outperform” rating and set a $20.00 price objective on the stock in a research note on Thursday, May 4th. Finally, TheStreet upgraded shares of Health Insurance Innovations from a “c” rating to a “b-” rating in a research note on Monday, May 22nd. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Health Insurance Innovations presently has an average rating of “Buy” and an average price target of $30.83.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another site, it was stolen and reposted in violation of United States & international copyright & trademark law. The legal version of this news story can be viewed at https://www.watchlistnews.com/health-insurance-innovations-hiiq-receives-daily-news-impact-rating-of-0-20/1534727.html.

In other Health Insurance Innovations news, CFO Michael D. Hershberger sold 5,000 shares of the stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $23.22, for a total value of $116,100.00. Following the transaction, the chief financial officer now owns 105,369 shares of the company’s stock, valued at $2,446,668.18. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Bruce Telkamp sold 11,501 shares of the stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $31.45, for a total value of $361,706.45. Following the completion of the transaction, the chief executive officer now directly owns 17,500 shares in the company, valued at approximately $550,375. The disclosure for this sale can be found here. Insiders sold 194,242 shares of company stock worth $5,088,007 in the last three months. Insiders own 30.00% of the company’s stock.

Health Insurance Innovations Company Profile

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

Insider Buying and Selling by Quarter for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Ratings for Health Insurance Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.